Rydzewska, LHM;
Burdett, S;
Vale, CL;
Parmar, MKB;
Tierney, JF;
(2018)
Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
European Journal of Cancer
, 94
pp. 218-229.
10.1016/j.ejca.2018.02.002.
Preview |
Text
Burdett LetterToEditor_EJC_Re ABI_07MAR2018_AcceptedManuscript.pdf - Accepted Version Download (372kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ejca.2018.02.002 |
| Publisher version: | https://doi.org/10.1016/j.ejca.2018.02.002 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10045527 |
Downloads since deposit
137Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
